Skip to search formSkip to main contentSkip to account menu

Budesonide / formoterol

Known as: BUDESONIDE/FORMOTEROL, formoterol and budesonide 
National Institutes of Health

Related topics

Related topics

2 relations
Budesonideformoterol

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
Budesonide/Formoterol for bronchiolitis obliterans after hematopoietic stem cell transplantation.
RATIONALE Systemic steroids are the standard treatment for bronchiolitis obliterans syndrome (BOS) after allogeneic hematopoietic… 
Review
2013
Review
2013
Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease.
BACKGROUND Both long-acting beta(2)-agonists and inhaled corticosteroids have been recommended in guidelines for the treatment of… 
Highly Cited
2009
Highly Cited
2009
The bioavailability and airway clearance of the steroid component of budesonide/formoterol and salmeterol/fluticasone after inhaled administration in patients with COPD and healthy subjects: a…
BackgroundAirway absorption and bioavailability of inhaled corticosteroids (ICSs) may0020be influenced by differences in… 
Highly Cited
2008
Highly Cited
2008
Efficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease: results of a 6-month…
BACKGROUND The combination of an inhaled corticosteroid (ICS) and a long-acting bronchodilator is recommended in the treatment of… 
Highly Cited
2008
Highly Cited
2008
Efficacy and Safety of Budesonide and Formoterol in One Pressurized Metered-Dose Inhaler in Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease
AbstractBackground: The combination of an inhaled corticosteroid (ICS) and a long-acting bronchodilator is recommended in the… 
Review
2007
Review
2007
Combined corticosteroid and long-acting beta-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease.
BACKGROUND Long-acting beta-agonists and inhaled corticosteroids have both been recommended in guidelines for the treatment of… 
Highly Cited
2006
Highly Cited
2006
Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial.
STUDY OBJECTIVE To compare a novel asthma management strategy--budesonide/formoterol in a single inhaler for both maintenance… 
Highly Cited
2003
Highly Cited
2003
Combination Therapy with Single Inhaler Budesonide/Formoterol Compared with High Dose of Fluticasone Propionate Alone in Patients with Moderate Persistent Asthma
BackgroundThe efficacy and safety of Symbicort®1 (budesonide and formoterol in a single inhaler) were compared with those of a… 
Highly Cited
2002
Highly Cited
2002
Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma
The aim of this study was to evaluate the efficacy (expressed as effect on lung function) and tolerability of Symbicort… 
Highly Cited
2001
Highly Cited
2001
Onset of bronchodilation of budesonide/formoterol vs. salmeterol/fluticasone in single inhalers.
Combinations of inhaled glucocorticoids and long-acting beta2-agonists in the same inhaler device have become available in recent… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)